GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

gremubamab   Click here for help

GtoPdb Ligand ID: 13374

Synonyms: MEDI3902
Compound class: Antibody
Comment: Gremubamab (MEDI3902) is a bivalent, bispecific monoclonal antibody [2]. It is under clinical development as a treatment for nosocomial pneumonia caused by Pseudomonas aeruginosa.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
No information available.
Summary of Clinical Use Click here for help
Gremubamab has progressed to Phase 2 clinical evaluation.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02255760 Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults Phase 1 Interventional MedImmune LLC
NCT02696902 Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects Phase 2 Interventional MedImmune LLC 1